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Background: Joubert syndrome (JS) is a recessively inherited
disorder characterised by hypotonia at birth and develop-
mental delay, followed by truncal ataxia and cognitive
impairment, characteristic neuroimaging findings (cerebellar
vermis hypoplasia, ‘‘molar tooth sign’’) and suggestive facial
features. JS is clinically heterogeneous with some patients
presenting with breathing abnormalities in the neonatal
period, oculomotor apraxia, retinal dystrophy, retinal
coloboma, ptosis, hexadactyly, and nephronophtisis or cystic
dysplastic kidneys. JS is also genetically heterogeneous, with
two known loci, on 9q34 (JBTS1) and 11p11-q12 (CORS2),
representing only a fraction of cases.
Methods: A large consanguineous Joubert family (five
affected) was analysed for linkage with a marker set covering
the entire genome and 16 smaller families were subsequently
tested for candidate loci.
Results: We report here the identification of a third locus in
6q23 (JBTS3) from the study of two consanguineous families.
LOD score calculation, including the consanguinity loops,
gave a maximum value of 4.1 and 2.3 at q = 0 for the two
families, respectively.
Conclusions: Linkage between the disease and the
D6S1620–D6S1699 haplotype spanning a 13.1 cM interval
is demonstrated. Genotype-phenotype studies indicate that,
unlike CORS2, JBTS3 appears not to be associated with renal
dysfunction.
J
oubert syndrome (JS) (also known as Joubert-
Boltshauser syndrome) is a recessively inherited disorder
first described by Joubert et al1 in a family of Canadian
origin and further characterised by Boltshauser and Isler2 in
families of Swiss and German origin. Since then, many cases
have been reported with various geographic origins. Con-
sistent features of this condition are developmental delay,
hypotonia, cerebellar ataxia, and suggestive facial features.
Abnormalities on axial MRI are the neuroimaging hallmarks
of JS, and include cerebellar vermis hypoplasia and abnorm-
alities at the pontomesencephalic junction that lead to a
characteristic ‘‘molar tooth’’ appearance.3 This neuro-
radiological pattern results from an abnormally deep inter-
peduncular fossa and thick superior cerebellar peduncles
orientated perpendicular to the brainstem. A wide clinical
variability within the sibships and between families is
observed with a marked variation in severity and the
inconsistent presence of the following features: episodic
apnea-hyperpnea which disappears with increasing age,
abnormal eye movements (jerky eye movements, nystagmus,
delay in saccadic initiation), rhythmic protrusion of the
tongue, occipital meningoencephalocele, polydactyly, nephrono-
phthisis or cystic dysplasia of the kidney, chorioretinal
coloboma, and retinal dysplasia. There is a significant clinical
overlap between JS and other cerebello-oculo-renal syndromes
(CORS) such as Arima, Senior-Loken, and COACH syndromes,
andfurthermolecularinvestigationsshouldhelptoachieveafinal
classification of these conditions.4 This wide clinical hetero-
geneity hampers the gathering together of families into
genetically homogeneous groups needed for linkage studies.
Indeed, the first linkage studies failed to identify a specific
chromosomal locus for JS providing evidence that JS and
related syndromes are genetically heterogeneous.5 6 In addi-
tion, candidate gene approaches have failed so far to detect
mutations in the WNT1, EN1, EN2, and FGF8 genes of
patients with JS.6 7 Homozygosity mapping can be used as an
alternative method to bypass the problem of genetic
heterogeneity by studying large consanguineous families
with autosomal recessive disorder.8 Using this strategy, Saar
et al identified a JS locus on chromosome 9q34.3 (JBTS1) in
two families of Omani origin.9 However most of the families
studied by Blair et al6 and by us (unpublished results) are
excluded for linkage to this locus. Recently, Valente et al10 and
Keeler et al11 identified a second JS locus associated with
nephronophtisis on chromosome 11p11-q12 (cerebello-oculo-
renal syndrome 2, CORS2). We report here the identification
of a third locus on 6q23 (JBTS3) from the study of two
consanguineous families, including the second reported JS
family.2 On the other hand, linkage to 6q23 was excluded for
nine out of 15 additional families diagnosed with JS, the
remaining families being too small to allow conclusions to be
drawn.
METHODS
Subjects
In family 1, of Turkish origin, five children born from
consanguineous parents have Joubert syndrome (fig 1,
table 1). All affected individuals have marked cognitive
impairment, requiring special education. Expressive speech
was markedly affected, and two children remained without
verbal communication. Motor milestones were extremely
slow and the ability to walk unaided was never reached
before the age of 7 years, reflecting hypotonia and truncal
ataxia. The patients had significantly reduced vision with
retinal dystrophy at later ages, but no nystagmus and no
retinal coloboma. Electroretinography was not performed.
There was no evidence of renal dysfunction and all patients
had normal serum creatinin levels at their present ages,
ranging from 17 to 28 years. Neuroimaging confirmed
cerebellar vermis hypoplasia and molar tooth sign. All
patients, the parents, and three out of five healthy siblings
were available for study.
Family 2, of Swiss origin, is one of the original families
described by Boltshauser and Isler.2 The parents are third
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Figure 1 Genotyping results of family 1 for the chromosome 6q23 region. DNA samples of healthy siblings II.1 and II.2 were not available for study.
Markers are indicated on the left and are organised from top to bottom in centromeric to telomeric order. The marker order is based on the UCSC
Assembly of Human Genome browser (April 2003 update, http://genome.ucsc.edu). Parental haplotypes linked with the disease are boxed. The
region of homozygosity by descent is highlighted in grey. Dotted lines indicate the centromeric and telomeric boundaries of the JBTS3 locus defined,
respectively, by a maternal recombination in patient II.5 and heterozygosity in patients due to an ancestral recombination (arrows).
Table 1 Clinical features of the JBTS3 patients
Clinical features Family 1 Family 2
Origin Turkey Switzerland
Patient 1 2 3 4 5* 1 2
Sex F M F M F F F
Present age (years) 28 27 23 21 17  23
Early hypotonia + + + + + + +
Age at independent walking (years) 10 10 9 WCB WCB  7
Cognitive impairment ++ ++ ++ ++++ ++++ NA +
Neonatal breathing problems NA NA NA NA NA + +
Cerebellar ataxia ¡ – + – 2 + +
Nystagmus 2 – + – 2 + +
Optic atrophy 2 – – – NA – –
Retinal dystrophy 2 + – – NA NA +
Reduced vision + + + + + NA +
Kyphoscoliosis + + – – 2 2 2
Retarded skeletal growth NA NA + + + – 2
Renal dysfunction 2 2 2 2 2 2` 2
MTS + + + + + +1 +
Cerebellar vermis hypoplasia + + + + + + +
F, female; M, male; NA, not available; MTS, molar tooth sign; WCB, wheelchair bound.
*Also presented with spasticity, microcephaly and seizures; deceased at 23 months; `normal kidney histology at
autopsy; 1abnormal ponto-mesencephalic junction and upper cerebellar pedoncules at autopsy.
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degree cousins and have two healthy children (fig 2). A
second affected daughter was born subsequently to the initial
report.12 13 The index patient had poor developmental pro-
gress and died at 23 months of age, before DNA sampling
was available. Her autopsy report14 was the first detailed
pathological description of JS. The surviving patient is now
23 years old and has a favourable, but clearly subnormal,
cognitive development, with independence in her daily
activities and fair reading and writing skills. She has normal
ultrasonography of kidney and liver, normal serum creatinin
levels, and no evidence of kidney involvement. She has pig-
mentary retinopathy, which has been non-progressive until
now, with flat electroretinogram since the age of 10 (table 1).
Fifteen additional families (22 patients in total) were also
included in the study. The selected families had at least one
healthy child available for genetic study or had documented
consanguinity. Fourteen patients have been previously
described.13 15 16 All patients conform to the following
diagnostic criteria: hypotonia and developmental delay,
followed by truncal ataxia and cognitive impairment,
presence on MRI of the molar tooth sign and cerebellar
vermis hypoplasia, and suggestive facial features (high-
rounded eyebrows, ptosis, broad nasal bridge with mild
epicanthus, anteverted nostrils, triangular shaped open
mouth, and low-set ears as illustrated in Maria et al17). In
addition, some patients presented with breathing abnormal-
ities in the neonatal period, abnormal eye movements, or
retinal dystrophy. Two patients, from two families, had renal
failure before 12 years of age followed by renal transplanta-
tion, and an affected brother had reduced cortico-medullary
differentiation on renal ultrasounds and high serum creati-
nin levels since the age of 10.
Figure 2 Genotyping results of family 2 for the chromosome 6q23 region. Markers and haplotypes are indicated as in figure 1. The patient is
homozygous for 23 consecutive markers, with the exception of D6S457 which is assumed to represent an ancient allelic mutation, since both parents
and transmitting grandparents carry different alleles at this locus. The patient is heterozygous for marker STR49 (arrow) and further telomeric markers,
allowing reduction of the critical interval. The dotted line defines the telomeric boundary of this interval.
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Genotyping
Blood samples were obtained with informed consent.
Genomic DNA was extracted from the peripheral blood
leukocytes by a standard phenol/chloroform method.
A whole-genome screen was initiated with family 1 using a
microsatellite marker set developed and commercialised by
PE Biosystems (ABI Linkage Mapping Set version 2, medium
density set 10, MD-10). This set comprises 400 fluorescently
labelled microsatellite markers selected from the Ge´ne´thon
human linkage map,18 with an average spacing of 10 cM and
an average heterozygosity of 75%. PCR-multiplex protocol
and fragment analysis were performed as described.19
Additional CA/TG microsatellite markers from the
Ge´ne´thon human linkage map18 and new polymorphic
markers were amplified with a universal fluoresceinated
primer as described.19 To identify new polymorphic markers,
we searched for (CA)n repeats in the corresponding sequence
of the human genome and designed flanking PCR primers for
repeats with more than 12 motif units. The primer sequences
of the new polymorphic markers, derived from the BAC
clones (http://genome.ucsc.edu), are given in table 2. All
annealing temperatures for PCR amplification were set at
60 C˚. PCR products were resolved on ABI 377 or ABI 3100
DNA sequencers (PE Applied Biosystems) and analysed using
ABI PRISM GeneScan Analysis Software.
Linkage analysis
Part of the linkage power of families 1 and 2 is due to the
consanguinity loop(s) and linkage is supported when the
patients are homozygous for a rare haplotype.8 This informa-
tion was included in a two-point LOD score calculation by
considering the non-recombinant haplotype as a single
locus.8 The frequency of the homozygous haplotype was
calculated as the product of the frequency of the individual
alleles estimated from a reference white population. In order
to eliminate biases due to possible linkage disequilibrium,
only one marker was taken into account when two were less
than 500 kb apart on the human genome sequence. Two-
point LOD scores with consanguinity loops were calculated by
using the MLINK program of the FASTLINK package.20 We
assumed a fully penetrant autosomal recessive mode of
inheritance, and a gene frequency of 0.001 that certainly
represents an upper limit for this rare condition.
RESULTS
A total of 390 markers of the ABI PRISM Linkage Mapping
Set were tested with family 1. Given the close consanguinity
of the parents and the close spacing of the markers, we
selected the regions for which at least one marker was
homozygous in all five affected individuals and heterozygous
in the three healthy siblings. We identified only one such
region, on chromosome 6q23, in which the consecutive
markers D6S262 and D6S292 were homozygous in all
patients. The study of a dense set of microsatellite markers
from this region confirmed linkage to the 6q23 locus, since
the five patients were homozygous for at least 16 consecutive
markers and the healthy siblings were heterozygous for 14 of
these markers (fig 1). LOD score calculation, including the
consanguinity loop,8 21 gave a value of 4.1 at a recombination
fraction h of 0, demonstrating linkage between the disease
and the 6q23 haplotype. On the centromeric side, a maternal
recombination in patient II.5 excluded marker D6S1620 from
linkage. On the other side, marker D6S1699 and further
telomeric markers were heterozygous in all patients, indicat-
ing the occurrence of an ancestral recombination. The
recombinant markers define a 13.1 cM interval containing
the JS gene.
The set of 6q23 microsatellite markers was tested in 16
smaller families, of which six had documented consangui-
nity. Linkage to 6q23 was excluded in nine families either
because patients and a healthy sibling shared the same
haplotypes or because homozygosity by descent was not
present in consanguineous families. Five of these families
were compatible with linkage to CORS2, and three to JBTS1,
including two compatible with both (LOD scores in favour of
linkage ranging from 0.25 to 1.1, not shown). Six families
were compatible with linkage to 6q23, albeit this is most
likely due to small family size in most cases (LOD scores in
favour of linkage ranging from 0.125 to 0.725), since five of
these families were equally linked to the CORS2 locus, and
two to the JBTS1 locus (not shown). In all cases, sufficient
markers were tested in order to have fully informative
families. Finally, linkage to 6q23 was demonstrated for
family 2. The affected patient was homozygous for 22
consecutive markers (with the exception of a probable allelic
mutation at D6S457) and the two healthy siblings did not
share the same haplotypes (fig 2). LOD score calculation,
including the consanguinity loops, gave a value of 2.3, at a
recombination fraction h of 0, demonstrating linkage
between the disease and the 6q23 locus in this family.22
Marker STR49, which is 1.3 Mb centromeric to D6S1699, as
well as more distal markers were heterozygous in the patient,
allowing us to reduce the critical interval and to exclude
seven genes located between STR49 and D6S1699 from being
candidate JS genes. The final interval is 8.2 Mb in size and
contains 45 known genes. None of them seemed to be a good
candidate gene for Joubert syndrome.
DISCUSSION
Despite early descriptions of JS in 1969 and 1977,1 2 and
numerous subsequent reports since then, the search for the
defective genes has remained elusive so far, mostly due to
tremendous heterogeneity both at the clinical and genetic
levels. Identification of a first JS locus on chromosome 9q34
(JBTS1),9 confirmed this heterogeneity, since most JS
families are not linked to this locus.6 9 We report here the
identification of another locus, on 6q23, based on homo-
zygosity of patients in two consanguineous families. While
the LOD score in favour of linkage in family 1 (4.1) is
sufficient to demonstrate the existence of this locus, the LOD
score for family 2 (2.3) is sufficient to confirm that it is linked
to the same locus as family 1. Here again, the JS locus
represents only a fraction of the JS families. Indeed, it is
anticipated that in most of the six small families for which
the disease segregates with 6q23 it does so by chance and
only a few subjects will have mutations in the 6q23 locus.
Another locus has recently been identified on chromosome
11p11-q12, based on the study of a large Sicilian consangui-
neous family10 and of three smaller consanguineous
families.11 In the Sicilian family, two patients also developed
Table 2 Primer sequences for PCR amplification of the
new microsatellite markers
Marker Primer sequence BAC clones Size (bp)
STR48 59-aagtcggtctgctgtttcca-39 AL358943 ,210
59-tgttcctaagtcttctctccatcc-39
STR55 59-atcaccactgatcccacaga-39 AL513524 ,190
59-gattcaacttcttcccggttt-39
STR52 59-ccaaaaggccaagagaaggt-39 AC068005 ,160
59-ggttggggagagatcacagg-39
STR53 59-acttctagtctggttccctagagttt-39 AC023293 ,220
59-tggctaaagtgtgttggcttc-39
STR47 59-agttttctggccccctctat-39 AL023284 ,230
59-caccttcatgggtgtccttt-39
STR49 59-tgctacgattgacccaactct-39 AL357060 ,220
59-caaccagtgaaaagcaacaca-39
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renal failure at age 17 and 15, respectively, while the two
youngest patients, aged 12 and 8 years, had only altered
urinary concentration test and no polyuria/polydipsia. Three
patients had increased kidney echogenicity but no renal cysts.
None had retinal abnormalities. Patients from the three
smaller families were clinically heterogeneous and presented
with either kidney cysts, suggestive nephrocalcinosis, poster-
ior encephalocele, hydrocephalus, corpus callosum and
occipital lobe dysplasia, coloboma of the retina, or retinal
dystrophy.11 The age at last examination of patients without
renal problems was not indicated. The 11p11-q12 locus was
named CORS2 for cerebello-oculo-renal syndrome, with
JBTS1 corresponding to CORS1. CORS2 patients contrast
with the six patients of families 1 and 2, who have not
developed renal failure past the age of 17. Moreover, reduced
vision with retinal dystrophy was found in both families,
while retinal presentation of CORS2 patients was more
heterogeneous. The 6q23 locus was therefore named JBTS3,
which may correspond to CORS3 if future linked families
reveal renal heterogeneity. The knowledge of three JS loci
opens up the possibility of investigating genotype/phenotype
correlations that should help clarify nosologic delineation
among CORS and facilitate the search for defective genes
from homogeneous patient groups.
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